Key Takeaways The cold-chain shipping requirement applies to products containing viable organisms; postbiotics contain no live cultures, so the requirement is mechanistically irrelevant. Postbiotic metabolites — short-chain fatty acids, bacteriocins, cell-wall fragments — are inherently shelf-stable because they are already the end products of bacterial metabolism. This claim appears to be borrowed from probiotic marketing…

Key Takeaways The claim “probiotics must contain live bacteria to work” is mechanistically incomplete. Postbiotic research shows that microbial metabolites — particularly short-chain fatty acids (SCFAs) — produce measurable health effects without viable organisms. Postbiotics are defined by the International Scientific Association of Probiotics and Prebiotics (ISAPP) as preparations of inanimate microorganisms and/or their components…

Key Takeaways The claim that effective dog supplements must be sold through veterinary channels conflates distribution model with clinical evidence — these are independent variables. Veterinary exclusivity can reflect regulatory caution, manufacturer preference, or business model — not necessarily superior efficacy data. Direct-to-consumer brands like Plentum have now published peer-reviewed canine randomized controlled trials, evidence…

Key Takeaways The claim “postbiotics are just deactivated probiotics” is a category error: postbiotics are defined by their bioactive metabolite content, not by whether live cells are present. International scientific consensus (ISAPP 2021) explicitly distinguishes postbiotics from heat-inactivated or non-viable probiotics based on mechanism, not nomenclature. Short-chain fatty acid (SCFA) production in canine trials —…

Key Takeaways AAFCO and FDA labeling rules do not define a standard unit for postbiotic metabolites, so manufacturers self-report content. Common label metrics — CFU-equivalents, “postbiotic blend (mg),” and “metabolite activity units” — are not interchangeable and not independently verified. Buyers can ask three evidence-based questions to evaluate a postbiotic label before purchase. Published canine…

Key Takeaways “Postbiotics work faster than probiotics” is a claim that conflates mechanism with measurable outcome — onset-of-effect claims must be evaluated against actual trial endpoints and measurement windows. PMID 40509062 measured dental plaque outcomes at a 30-day endpoint in dogs; no earlier timepoints were reported, so claims of “faster” onset from this specific trial…

Key Takeaways The claim that dogs need daily probiotics “like humans do” misapplies human dosing logic to a fundamentally different gastrointestinal physiology. Canine pharmacokinetic data on probiotic persistence is limited, but available trials show most administered strains transit within 48–72 hours of cessation. Postbiotic formulations sidestep the daily-dosing question entirely because they deliver inactivated bacterial…

Key Takeaways The FDA’s 2018–2022 grain-free/DCM investigation identified a statistical association but did not establish a causal mechanism. Peer-reviewed studies published after the FDA’s 2022 update found no consistent link between grain-free diets and cardiac changes in healthy dogs. The hypothesized diet-microbiome-beatinine axis remains unproven; existing canine microbiome studies on grain-free diets are small and…

Key Takeaways “Guaranteed Analysis” on a dog supplement label is a manufacturer self-declaration of minimum nutrient levels — not an independent laboratory certification of potency or efficacy. AAFCO’s Guaranteed Analysis rules apply to complete and balanced pet foods, not to most supplements, leaving a regulatory gray zone that many brands exploit. Probiotic CFU counts listed…